Home›Research›Compare›KPV vs Larazotide
Peptide ComparisonKPV vs Larazotide
Both are Tissue Repair peptides.
KPV
Lys-Pro-Val
Half-life: Short (minutes to hours)
102 providers listed
Larazotide
AT1001
Half-life: ~30 minutes (local gut action)
11 providers listed
Larazotide carries stronger published evidence (RCT, 3 key studies) than KPV (Cohort study, 6); both are research compounds.
KPV
Evidence
Half-life
Short (minutes to hours)
Larazotide
Evidence
Half-life
~30 minutes (local gut action)
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | Larazotide |
| Further along in FDA review | Larazotide |
| More provider options (102 vs 11) | KPV |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
KPV
Larazotide
KPV
Lysine-proline-valine peptide attenuates hepatic lipid accumulation through ROS-dependent regulation of the P…
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodyb…
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodyb…
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodyb…
+2 more
Larazotide
Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized control…
Potassium-Competitive Acid Blocker Increases Ileal Permeability and Exacerbates Ileal Inflammation under Stre…
A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during glu…
About KPV
Derived from alpha-MSH; binds melanocortin receptors MC1R/MC3R to suppress NF-κB and inflammatory cytokines
About Larazotide
Synthetic octapeptide that prevents zonulin-mediated tight junction opening; maintains intestinal epithelial barrier integrity
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
KPV
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Larazotide
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
KPV
Larazotide
Not enough vendor pricing yet.
Where to source these peptides
KPV
102 listed
Browse directory →
Providers offeringLarazotide
11 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Tissue Repair Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated July 22, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). KPV vs Larazotide — Per-mg Price Comparison. Retrieved July 22, 2026, from https://peptidebase.io/peptides/compare/kpv/larazotide